Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4636486019 | Product containing only teneligliptin in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4636487011 | Teneligliptin only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only teneligliptin in oral dose form (medicinal product form) | est un(e) (attribut) | Product containing teneligliptin in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing only teneligliptin in oral dose form (medicinal product form) | est un(e) (attribut) | Teneligliptin only product | true | Inferred relationship | Some | ||
| Product containing only teneligliptin in oral dose form (medicinal product form) | a une forme pharmaceutique (attribut) | forme orale | true | Inferred relationship | Some | ||
| Product containing only teneligliptin in oral dose form (medicinal product form) | a pour principe actif (attribut) | Teneligliptin (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely teneligliptin (as teneligliptin hydrobromide) 20 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | True | Product containing only teneligliptin in oral dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR